Clinical Trial
Tienilic acid in mild to moderate hypertension
- PMID: 41229
Item in Clipboard
Clinical Trial
Tienilic acid in mild to moderate hypertension
Postgrad Med J.
1979.
Abstract
Tienilic acid has blood pressure lowering properties alone and in combined treatment with beta-adrenergic blocking agents; 250 mg of tienilic acid seems to correspond to 50 mg of hydrochlorothiazide. Tienilic acid effectively reduces serum urate and has no marked or rapid effect on potassium balance. During short-term treatment, no impairment of glucose tolerance was found.
Similar articles
-
Long-term usage of tienilic acid in essential hypertension.Postgrad Med J. 1979;55 Suppl 3:120-6. Postgrad Med J. 1979. PMID: 388397 Clinical Trial.
-
A double-blind study of tienilic acid with two year follow-up of patients with mild to moderate essential hypertension.Postgrad Med J. 1979;55 Suppl 3:103-9. Postgrad Med J. 1979. PMID: 388395 Clinical Trial.
-
The hypouricaemic effect of tienilic acid: experience in patients with hyperuricaemia.Postgrad Med J. 1979;55 Suppl 3:75-80. Postgrad Med J. 1979. PMID: 388400 Clinical Trial.
-
The treatment of mild to moderate essential hypertension with tienilic acid (ticrynafen).S Afr Med J. 1980 Jun 28;57(26):1069-72. S Afr Med J. 1980. PMID: 6996137 Clinical Trial.
-
Propranolol and tienilic acid in essential hypertension.Postgrad Med J. 1979;55 Suppl 3:115-9. Postgrad Med J. 1979. PMID: 388396 Clinical Trial.